NCT02197806 - Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2014

Conditions

Presbyopia

Interventions

DRUG

AGN-199201

1 to 2 drops of AGN-199201 ophthalmic solution in the eye(s) as per protocol.

DRUG

AGN-190584

1 to 2 drops of AGN-190584 ophthalmic solution in the eye(s) as per protocol.

DRUG

AGN-199201 Vehicle

1 to 2 drops of AGN-199201 vehicle in the eye(s) as per protocol.

Trial Locations (1)

Newport Beach